Abbott Laboratories

Abbott Laboratories is a global healthcare company with a diversified portfolio spanning four major segments: Medical Devices (including electrophysiology, rhythm management, heart failure, vascular, structural heart, neuromodulation, and diabetes care with its FreeStyle Libre continuous glucose monitoring platform), Diagnostics (core laboratory diagnostics, rapid and molecular diagnostics, and cancer diagnostics following the 2026 acquisition of Exact Sciences and its Cologuard colorectal cancer screening platform), Nutrition (pediatric and adult nutritional products sold globally), and Established Pharmaceuticals (branded generic medicines sold primarily in key emerging markets across Latin America, Asia Pacific, and other international regions). The company employs approximately 122,000 people and serves customers in more than 160 countries. Abbott's medical devices business accounts for the largest share of revenue, with continuous glucose monitors and electrophysiology products among its fastest-growing product lines. Updated Jul 16, 2026